4.8 Article

Engineering peptide linkers for scFv immunosensors

Journal

ANALYTICAL CHEMISTRY
Volume 80, Issue 6, Pages 1910-1917

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ac7018624

Keywords

-

Funding

  1. NCI NIH HHS [P30 CA068485, 5P30 CA68485-07] Funding Source: Medline
  2. NIBIB NIH HHS [1R21EB000672-01, R33 EB000672, R33 EB000672-05, R21 EB000672, R33 EB000672-04, 4R33EB000672-02] Funding Source: Medline
  3. NIEHS NIH HHS [P30 ES000267, 5P30 ES00267-36] Funding Source: Medline

Ask authors/readers for more resources

Using A10B single-chain fragment variable (scFv) as a model system, we demonstrated that the flexibility of scFv linker engineering can be combined with the inherent quick and adaptable characters of surface coupling chemistry (e.g., electrostatic, hydrogen bonding, or covalent attachment) to attach scFv to preformed functionalized self-assembled monolayers (SAMs). Six arginines, which were separated by glycine or serine as spacer, were incorporated in the peptide linker to form a 15-mer peptide linker (RGRGRGRGRSRGGGS). The polycationic arginine peptide was engineered into the A10B scFv-RG3 to favor its adsorption at anionic charged template surface (11-mercaptoundecanoic acid (MUA) and poly(sodium 4-styrenesulfonate (PSS))). Ibis new approach was compared with the other engineered scFv constructs. Our results demonstrated that the anionic charged SAM template facilitated the oriented immobilization of scFvs on the SAM template surface as well as reduced the possibility of protein denaturation when directly immobilized on the solid surface. A 42-fold improvement of detection limits using MUA/A10B scFv-RG3 (less than 0.2 nM experimentally determined) was achieved compared to A10B Fab antibody and a 5-fold improvement was observed compared to A10B scFv that was engineered with a cysteine in the linker sequence. Using protein A-coated gold nanoparticles, a picomolar experimental detection limit was achieved. With 20 amino acids to choose from, engineered recombinant scFv in combination with SAM technology and nanoparticle mass amplification provide an emerging strategy for the development of highly sensitive and specific scFv immunosensors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available